TGA Approval

BAVENCIO avelumab (rch) 200 mg/10 mL concentrated solution for intravenous infusion vial (282729)

ARTG ID

282729

ARTG Name

BAVENCIO avelumab (rch) 200 mg/10 mL concentrated solution for intravenous infusion vial

Sponsor

Merck Healthcare Pty Ltd

ARTG Date

January 3, 2018

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Merck Healthcare Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/740fd0ffe4957283c633e507012fc32f.pdf

https://medical-cdn.nocode.com/drug_tga/b87aeab0805a1ad163a892f7c891039f.pdf

Ingredient Name

avelumab

Empowering clinical research with data-driven insights and AI-powered tools.

BAVENCIO avelumab (rch) 200 mg/10 mL concentrated solution for intravenous infusion vial (282729) - TGA 批准文号 | MedPath